Key result
Quantitative MRI links myofibrillar myopathy to increased fat, lower potassium, and ~140% higher tissue sodium.
Why the study?
Myofibrillar myopathies are clinically and genetically heterogeneous protein aggregate diseases, and it was unknown whether a novel quantitative MRI protocol could reveal new structural and biochemical muscle pathology in classic subtypes.
Does multi-parametric MRI at 3 T and 7 T reveal structural and biochemical muscle pathology in patients with myofibrillar myopathies compared to healthy controls?
Population
9 MFM patients, 1 patient with non-MFM distal myopathy, and 10 age-matched healthy controls
Comparison
Myopathy patients vs age-matched healthy controls
Design
Pilot case-control study
Authors
Loading...
Supports multi-parametric MRI to quantify muscle pathology in MFM; extends biomarkers for trials but should not yet change practice.
Does multi-parametric MRI at 3 T and 7 T reveal structural and biochemical muscle pathology in patients with myofibrillar myopathies compared to healthy controls?
Multi-parametric MRI at 3T and 7T can objectively quantify fat, edema-like changes, and potassium/sodium ion imbalances in the skeletal muscles of patients with myofibrillar myopathies.
Mathy et al. (2026) studied this question. Quantitative MRI in myofibrillar myopathy patients revealed significantly increased fat fractions, elevated tissue sodium (55.6 vs 23.2 mM), and reduced potassium (75.4 vs 108.9 mM) versus controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: